文献速递呼吸道感染

糖皮质激素对社区获得性肺炎死亡率和临床治愈的影响:随机对照试验的系统评价、荟萃分析和荟萃回归

Effect of Corticosteroids on Mortality and Clinical Cure in Community-Acquired Pneumonia: A Systematic Review, Meta-analysis, and Meta-regression of Randomized Control Trials.
PubMed 文献 · Chest · 2022-09-07

该系统评价纳入16项随机对照试验,评估住院细菌性社区获得性肺炎(CAP)患者使用全身糖皮质激素的获益。

要点

  • 住院CAP患者使用糖皮质激素可降低机械通气需求(RR 0.51,95%CI 0.33-0.77)。

核心结论

  • 住院CAP患者使用糖皮质激素与较低的机械通气需求相关,但与死亡率、治疗失败或不良事件无显著关联。

研究设计与样本

  • 系统评价、荟萃分析和试验序贯分析,检索PubMed、Cochrane Library和Embase,纳入16项比较全身糖皮质激素与标准治疗的随机对照试验。

临床怎么用

  • 对于住院的细菌性CAP患者,可考虑使用全身糖皮质激素以降低进展至需要机械通气的风险。
  • 决策时应权衡激素治疗对再住院率的潜在影响。

局限性

  • 原文未报告具体局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality. Corticosteroids may be a beneficial adjunct in the treatment of bacterial pneumonia. RESEARCH QUESTION: Is there any benefit of corticosteroid therapy in the management of bacterial CAP among patients requiring hospitalization? STUDY DESIGN AND METHODS: PubMed, Cochrane Library, and Embase were searched to identify randomized controlled trials assessing the use of systemic corticosteroids compared with standard care in the management of CAP. A systematic review, meta-analysis, and Trial Sequential Analysis (TSA) were performed. The primary outcome was all-cause mortality. Secondary outcomes included ICU admission, mechanical ventilation, treatment failure, readmission, and adverse events. Data are presented as risk ratio (RR) with 95% CI, P value, heterogeneity (I2), and TSA-adjusted CIs. RESULTS: Sixteen trials met the eligibility criteria. All-cause mortality (16 studies [3,842 patients]; RR, 0.85 [95% CI, 0.67-1.07]; P = .17; I2 = 14%; TSA-adjusted CI, 0.61-1.09), ICU admission (six studies [2,619 patients]; RR, 0.66 [95% CI, 0.45-0.97]; P = .04; I2 = 0%; TSA-adjusted CI, 0.37-1.12), treatment failure (six studies [2,093 patients]; RR, 0.78 [95% CI, 0.37-1.67]; P = .52; I2 = 68%; TSA-adjusted CI, 0.02-25.5), and the incidence of adverse events (six studies [2,487 patients]; RR, 1.10 [95% CI, 0.97-1.25]; P = .14; I2 = 53%; TSA-adjusted CI, 0.82-2.41) were similar between patients receiving corticosteroids and patients assigned to the control group. The need for mechanical ventilation (eight studies [1,457 patients]; RR, 0.51 [95% CI, 0.33-0.77]; P = .001; I2 = 0%; TSA-adjusted CI, 0.20-0.85) was lower among patients receiving corticosteroids compared with those receiving standard care. However, corticosteroid use may be associated with higher rates of hospital readmission (five studies [2,853 patients]; RR, 1.20 [95% CI, 1.05-1.38]; P = .008; I2 = 0%; TSA-adjusted CI, 0.89-1.98). INTERPRETATION: Corticosteroid therapy is associated with a lower incidence of progression to requiring mechanical ventilation among patients hospitalized with CAP. No association was found between corticosteroid therapy and mortality, treatment failure, or adverse events. TRIAL REGISTRY: PROSPERO; No.: CRD42021279359; URL: https://www.crd.york.ac.uk/prospero/.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Saleem, Kulkarni, Snow, et al. Effect of Corticosteroids on Mortality and Clinical Cure in Community-Acquired Pneumonia: A Systematic Review, Meta-analysis, and Meta-regression of Randomized Control Trials. Chest. 2022. PMID: 36087797. doi:10.1016/j.chest.2022.08.2229

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。